Deficiency of the Pyruvate Dehydrogenase Component in Pyruvate Dehydrogenase Complex-deficient Human Fibroblasts
Linda Ho, Seymour Packman, Mulchand S. Patel
Abstract
Linda Ho, Seymour Packman, Mulchand S. Patel
Abstract
A previously reported deficiency of total pyruvate dehydrogenase complex activity is further characterized. Dihydrolipoyl transacetylase (E2) and lipoamide dehydrogenase (E3) activities in the patient's fibroblasts were normal. Pyruvate dehydrogenase activity (El) was 33% ofthat in fibroblasts from an age-matched control. The amounts of each of the components of pyruvate dehydrogenase complex were analyzed using an immunoblot technique and specific antibodies. Levels of components E2 and E3 were the same in fibroblasts from the patient and control, confirming the activity measurements. However, the levels of Ela and Elft were reduced markedly in fibroblasts from the patient. Thus, impairment in the pyruvate dehydrogenase complex activity was due to a reduction in the amount ofthe El component of the complex.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A previously reported deficiency of total pyruvate dehydrogenase complex activity is further characterized. Dihydrolipoyl transacetylase (E2) and lipoamide dehydrogenase (E3) activities in the patient's fibroblasts were normal. Pyruvate dehydrogenase activity (El) was 33% ofthat in fibroblasts from an age-matched control. The amounts of each of the components of pyruvate dehydrogenase complex were analyzed using an immunoblot technique and specific antibodies. Levels of components E2 and E3 were the same in fibroblasts from the patient and control, confirming the activity measurements. However, the levels of Ela and Elft were reduced markedly in fibroblasts from the patient. Thus, impairment in the pyruvate dehydrogenase complex activity was due to a reduction in the amount ofthe El component of the complex.
Key concepts: Pyruvate dehydrogenase complex, Dihydrolipoyl transacetylase, Pyruvate dehydrogenase phosphatase, Pyruvate dehydrogenase kinase, Oxoglutarate dehydrogenase complex, Pyruvate decarboxylation, Pyruvate dehydrogenase lipoamide kinase isozyme 1, Branched-chain alpha-keto acid dehydrogenase complex